Integration of Transcriptome and Interactome Predicts an ETP-ALL-Specific Transcriptional Footprint That Decodes Its Developmental Propensity

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2022 Jun 1

PMID 35646901

Authors

Soumyadeep Mukherjee

Arpita Kar

Paramita Paul

Souvik Dey

Avik Biswas

Subhasis Barik

Affiliations

Soon will be listed here.

Abstract

Early T precursor acute lymphoblastic leukemia (ETP-ALL) exhibits poor clinical outcomes and high relapse rates following conventional chemotherapeutic protocols. Extensive developmental flexibility of the multipotent ETP-ALL blasts with considerable intra-population heterogeneity in terms of immunophenotype and prognostic parameters might be a target for novel therapeutic interventions. Using a public gene expression dataset (GSE28703) from NCBI GEO DataSets with 12 ETP-ALL and 40 non-ETP-ALL samples, such heterogeneity was found to be reflected in their transcriptome as well. Hub genes were identified from the STRING-derived functional interaction network of genes showing differential expression between ETP-ALL and non-ETP-ALL as well as variable expression across ETP-ALL. Nine genes (, , , , , , , and ) among the hubs were further validated as possible diagnostic ETP-ALL markers using another gene expression dataset (GSE78132) with 17 ETP-ALL and 27 non-ETP-ALL samples. Linear dimensionality reduction analysis with the expression levels of the hub genes in ETP-ALL revealed their divergent inclinations towards different hematopoietic lineages, proposing them as novel indicators of lineage specification in the incompletely differentiated ETP-ALL blasts. This further led to the formulation of a personalized lineage score calculation algorithm, which uncovered a considerable B-lineage-bias in a substantial fraction of ETP-ALL subjects from the GSE28703 and GSE78132 cohorts. In addition, STRING-derived physical interactome of the potential biomarkers displayed complete segregation of the B-lineage-skewed markers from other lineage-associated factors, highlighting their distinct functionality and possible druggability in ETP-ALL. A panel of these biomarkers might be useful in pinpointing the dominant lineage specification programmes in the ETP-ALL blasts on a personalized level, urging the development of novel lineage-directed precision therapies as well as repurposing of existing therapies against leukemia of different hematopoietic lineages; which might overcome the drawbacks of conventional chemotherapy.

Citing Articles

RORγt inverse agonists demonstrating a margin between inhibition of IL-17A and thymocyte apoptosis.

Collins M, Pehrson R, Grindebacke H, Leffler A, Ramnegard M, Rannikmae H PLoS One. 2025; 20(1):e0317090.

PMID: 39820614 PMC: 11737796. DOI: 10.1371/journal.pone.0317090.

The Proteomics of T-Cell and Early T-Cell Precursor (ETP) Acute Lymphocytic Leukemia: Prognostic Patterns in Adult and Pediatric-ETP ALL.

Hoff F, Sriraja L, Qiu Y, Jenkins G, Teachey D, Wood B Cancers (Basel). 2025; 16(24).

PMID: 39766140 PMC: 11674289. DOI: 10.3390/cancers16244241.

Construction of a Wilms tumor risk model based on machine learning and identification of cuproptosis-related clusters.

Huang J, Li Y, Pan X, Wei J, Xu Q, Zheng Y BMC Med Inform Decis Mak. 2024; 24(1):325.

PMID: 39497055 PMC: 11536559. DOI: 10.1186/s12911-024-02716-8.

Identification of two key biomarkers CD93 and FGL2 associated with survival of acute myeloid leukaemia by weighted gene co-expression network analysis.

Han H, Liu J, Zhu S, Zhao T J Cell Mol Med. 2024; 28(14):e18552.

PMID: 39054581 PMC: 11272607. DOI: 10.1111/jcmm.18552.

Novel hematopoietic progenitor kinase 1 inhibitor KHK-6 enhances T-cell activation.

Ahn M, Kim E, Choi Y, Chae C, Kim P, Kim S PLoS One. 2024; 19(6):e0305261.

PMID: 38923962 PMC: 11207149. DOI: 10.1371/journal.pone.0305261.

References

Verbeke D, Gielen O, Jacobs K, Boeckx N, De Keersmaecker K, Maertens J . Ruxolitinib Synergizes With Dexamethasone for the Treatment of T-cell Acute Lymphoblastic Leukemia. Hemasphere. 2020; 3(6):e310. PMC: 6924552. DOI: 10.1097/HS9.0000000000000310. View

Khurana S, Melody M, Ketterling R, Peterson J, Luoma I, Vazmatzis G . Molecular and phenotypic characterization of an early T-cell precursor acute lymphoblastic lymphoma harboring PICALM-MLLT10 fusion with aberrant expression of B-cell antigens. Cancer Genet. 2019; 240:40-44. DOI: 10.1016/j.cancergen.2019.11.002. View

Patrick K, Wade R, Goulden N, Mitchell C, Moorman A, Rowntree C . Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003. Br J Haematol. 2014; 166(3):421-4. DOI: 10.1111/bjh.12882. View

Babicki S, Arndt D, Marcu A, Liang Y, Grant J, Maciejewski A . Heatmapper: web-enabled heat mapping for all. Nucleic Acids Res. 2016; 44(W1):W147-53. PMC: 4987948. DOI: 10.1093/nar/gkw419. View

Della Chiara V, Daxinger L, Staal F . The Route of Early T Cell Development: Crosstalk between Epigenetic and Transcription Factors. Cells. 2021; 10(5). PMC: 8147249. DOI: 10.3390/cells10051074. View

Kuleshov M, Jones M, Rouillard A, Fernandez N, Duan Q, Wang Z . Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016; 44(W1):W90-7. PMC: 4987924. DOI: 10.1093/nar/gkw377. View

Barik S, Cattin-Roy A, Miller M, Ukah T, Zaghouani H . IL-4 and IL-13 Guide Early Thymic Progenitors To Mature toward Dendritic Cells. J Immunol. 2018; 201(10):2947-2958. PMC: 6219934. DOI: 10.4049/jimmunol.1701186. View

Maude S, Dolai S, Delgado-Martin C, Vincent T, Robbins A, Selvanathan A . Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia. Blood. 2015; 125(11):1759-67. PMC: 4357583. DOI: 10.1182/blood-2014-06-580480. View

Booth C, Barkas N, Neo W, Boukarabila H, Soilleux E, Giotopoulos G . Ezh2 and Runx1 Mutations Collaborate to Initiate Lympho-Myeloid Leukemia in Early Thymic Progenitors. Cancer Cell. 2018; 33(2):274-291.e8. DOI: 10.1016/j.ccell.2018.01.006. View

10.

Ravichandran S, Banerjee U, Dr G, Kandukuru R, Thakur C, Chakravortty D . VB, a new blood biomarker for differential diagnosis and recovery monitoring of acute viral and bacterial infections. EBioMedicine. 2021; 67:103352. PMC: 8099739. DOI: 10.1016/j.ebiom.2021.103352. View

11.

Neumann M, Heesch S, Schlee C, Schwartz S, Gokbuget N, Hoelzer D . Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations. Blood. 2013; 121(23):4749-52. DOI: 10.1182/blood-2012-11-465138. View

12.

Zuurbier L, Gutierrez A, Mullighan C, Cante-Barrett K, Gevaert A, de Rooi J . Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors. Haematologica. 2013; 99(1):94-102. PMC: 4007923. DOI: 10.3324/haematol.2013.090233. View

13.

Bagger F, Kinalis S, Rapin N . BloodSpot: a database of healthy and malignant haematopoiesis updated with purified and single cell mRNA sequencing profiles. Nucleic Acids Res. 2018; 47(D1):D881-D885. PMC: 6323996. DOI: 10.1093/nar/gky1076. View

14.

Bernt K, Hunger S, Neff T . The Functional Role of PRC2 in Early T-cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) - Mechanisms and Opportunities. Front Pediatr. 2016; 4:49. PMC: 4870860. DOI: 10.3389/fped.2016.00049. View

15.

Yang Y, Yao S, Zhang J, Yan Z, Chu J, Wang H . Decitabine-containing G-CSF priming regimen overcomes resistance of primary mediastinal neoplasm from early T-cell precursors to conventional chemotherapy: a case report. Onco Targets Ther. 2019; 12:7039-7044. PMC: 6718739. DOI: 10.2147/OTT.S214905. View

16.

Chin C, Chen S, Wu H, Ho C, Ko M, Lin C . cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014; 8 Suppl 4:S11. PMC: 4290687. DOI: 10.1186/1752-0509-8-S4-S11. View

17.

Jeremiah Bell J, Bhandoola A . The earliest thymic progenitors for T cells possess myeloid lineage potential. Nature. 2008; 452(7188):764-7. DOI: 10.1038/nature06840. View

18.

Treanor L, Zhou S, Janke L, Churchman M, Ma Z, Lu T . Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential. J Exp Med. 2014; 211(4):701-13. PMC: 3978278. DOI: 10.1084/jem.20122727. View

19.

Bene M, Castoldi G, Knapp W, Ludwig W, Matutes E, Orfao A . Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia. 1995; 9(10):1783-6. View

20.

Chen E, Tan C, Kou Y, Duan Q, Wang Z, Meirelles G . Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013; 14:128. PMC: 3637064. DOI: 10.1186/1471-2105-14-128. View